Literature DB >> 206087

Effects of bromocriptine on the hypothalamo-pituitary axis.

E Flückiger.   

Abstract

The effects of bromocriptine on the secretion of prolactin, gonadotrophins, thyretrophin (TSH), corticotrophin (ACTH), somatotrophin (GH) and melanocyte-stimulating hormone (MSH) in mammals are presented and the sites and mode of action briefly discussed.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 206087

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN： 0300-9750


  7 in total

1.  Five-year clinical follow-up of prostatic cancer patients treated with fosfestrol and bromocriptine.

Authors:  L Jeromin; J Wiśniewski; M Rozniecki; Z Janiak; J Borkiewicz
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

2.  Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.

Authors:  E Flückiger; U Briner; W Doepfner; E Kovacs; P Marbach; H R Wagner
Journal:  Experientia       Date:  1978-10-15

3.  Effect of prolactin suppression on the ovarian activity in the lactating sow.

Authors:  E Benjaminsen
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

4.  Effects of fibroblast growth factor and bromocriptine on the mitotic activity of the anterior pituitary gland in organ culture.

Authors:  M Pawlikowski; H Stepień
Journal:  Cell Tissue Res       Date:  1979-10-02       Impact factor: 5.249

Review 5.  Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.

Authors:  D M Jackson; O F Jenkins
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.

Authors:  D M Jackson; M Hashizume
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.

Authors:  D M Jackson; S B Ross; M Hashizume
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.